Involvement of cyclooxygenase-1 and cyclooxygenase-2 activity in the therapeutic effect of ghrelin in the course of ethanol-induced gastric ulcers in rats

Journal of Physiology and Pharmacology

Volumn 65, Issue 1, 2014, Pages 95-106

  Warzecha, Zygmunt ^a   Ceranowicz, P ^a   Dembinski, M ^a   Cieszkowski, J ^a   Ginter, G ^a   Ptak Belowska, A ^a   Dembinski, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cell proliferation; Cyclooxygenase; Gastric ulcer; Ghrelin; Interleukin 1beta; Mucosal blood flow; Tumor necrosis factor 1alpha

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ALCOHOL; BETA ACTIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GHRELIN; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL ANALYSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVITY; MALE; MUCOSAL DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH BIOPSY; STOMACH BLOOD FLOW; STOMACH ULCER;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DNA; ETHANOL; GHRELIN; INTERLEUKIN-1BETA; MALE; MEMBRANE PROTEINS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; RNA, MESSENGER; STOMACH; STOMACH ULCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896840824     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999; 402: 656-660.
2. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758.
3. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-2991.
4. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540-2547.
5. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5995.
6. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50: 2438-2443.
7. Toshinai K, Date Y, Murakami N, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003; 144, 1506-1512.
8. Riediger T, Traebert M, Schmid HA, Scheel C, Lutz TA, Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci Lett 2003; 341: 151-155.
9. Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetitestimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 2001; 120: 337-345.
10. Currie PJ, Coiro CD, Duenas R, Guss JL, Mirza A, Tal N. Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization. Brain Res 2011; 1385: 127-134.
11. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ghrelin attenuates the development of acute pancreatitis in rats. J Physiol Pharmacol 2003; 54: 561-573.
12. Dembinski A, Warzecha Z, Ceranowicz P, et al. Role of growth hormone and insulin-like growth factor-1 in the protective effect of ghrelin in ischemia/reperfusion-induced acute pancreatitis. Growth Horm IGF Res 2006; 16: 348-356.
13. Warzecha Z, Ceranowicz P, Dembinski A, et al. Therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis in rats. J Physiol Pharmacol 2010; 61: 419-427.
14. Ceranowicz D, Warzecha Z, Dembinski A, et al. Role of hormonal axis, growth hormone-IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis. J Physiol Pharmacol 2010; 61: 599-606.
15. Sibilia V, Rindi G, Pagani F, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-359.
16. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin-a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325-336.
17. Brzozowski T, Konturek PC, Konturek SJ, et al. Exogenous and endogenous ghrelin in gastroprotection against stressinduced gastric damage. Regul Pept 2004; 120: 39-51.
18. Iseri SO, Sener G, Yuksel M, et al. Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 2005; 187: 399-406.
19. Ceranowicz P, Warzecha Z, Dembinski A, et al. Treatment with ghrelin accelerates the healing of acetic acid-induced gastric and duodenal ulcers in rats. J Physiol Pharmacol 2009; 60: 87-98.
20. Brzozowski T, Szlachcic A, Pajdo R, et al. Role of a new appetite hormones ghrelin, orexin-A and obestatin in the mechanism of healing of chronic gastric ulcers. In: Peptic Ulcer Disease, Jianyuan Chai (ed.). Rijeka, InTech, 2011, pp. 187-208.
21. Warzecha Z, Ceranowicz D, Dembinski A, et al. Ghrelin accelerates the healing of cysteamine-induced duodenal ulcers in rats. Med Sci Monit 2012; 18: BR181-BR187.
22. Warzecha Z, Kownacki P, Ceranowicz P, Dembinski M, Cieszkowski J, Dembinski A. Ghrelin accelerates the healing of oral ulcers in non-sialoadenectomized and sialoadenectomized rats. J Physiol Pharmacol 2013; 64: 657-668.
23. Konturek PC, Brzozowski T, Engel M, et al. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J Physiol Pharmacol 2009; 60: 41-47.
24. Deboer MD. Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations. Int J Pept 2011; 2011: 189242. doi: 10.1155/2011/189242.
25. Pamukcu O, Kumral ZN, Ercan F, Yegen BC, Ertem D. Antiinflammatory effect of obestatin and ghrelin in dextran sulfate sodium-induced colitis in rats. J Pediatr Gastroenterol Nutr 2013; 57: 211-218.
26. Matsui H, Shimokawa O, Kaneko T, Nagano Y, Rai K, Hyodo I. The pathophysiology of non-steroidal antiinflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine. J Clin Biochem Nutr 2011; 48: 107-111.
27. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and 2. J Biol Chem 1996; 271: 33157-33160.
28. Masferrer IL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and ulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232.
29. Konturek SJ, Piastucki I, Brzozowski T, et al. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981; 80: 4-9.
30. Peskar BM. Role of cyclooxygenase isoforms in gastric mucosal defence. J Physiol-Paris 2001; 95: 3-9.
31. Mizuno H, Sakamoto C, Matsuda K, et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 1997; 112: 387-397.
32. Brzozowski T, Konturek PC, Konturek SJ, et al. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and-2. Digestion 2001; 64: 15-29.
33. Pawlik M, Pajdo R, Kwiecien S, et al. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines. J Physiol Pharmacol 2011; 62: 75-86.
34. Zwolinska-Wcislo M, Brzozowski T, Ptak-Belowska A, et al. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J Gastroenterol 2011; 17: 4076-4089.
35. Warzecha Z, Dembinski A, Brzozowski T, et al. Gastroprotective effect of histamine and acid secretion on ammonia-induced gastric lesions in rats. Scand J Gastroenterol 2000; 35: 916-924.
36. Warzecha Z, Dembinski A, Ceranowicz P, et al. Role of sensory nerves in gastroprotective effect of anandamide in rats. J Physiol Pharmacol 2011; 62: 207-217.
37. Kwiecien S, Ptak-Belowska A, Krzysiek-Maczka G, et al. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, interacts with gastric oxidative metabolism and enhances stress-induced gastric lesions. J Physiol Pharmacol 2012; 63: 515-524.
38. Dembinski A, Warzecha Z, Ceranowicz P, et al. Administration of obestatin accelerates the healing of chronic gastric ulcers in rats. Med Sci Monit 2011; 17: BR196-BR200.
39. Sorbye H, Svanes K. The role of blood flow in gastric mucosal defence, damage and healing. Dig Dis 1994; 12: 305-317.
40. Warzecha W, Dembinski A, Brzozowski T, Ceranowicz P, Stachura J, Konturek SJ. Histamine in stress ulcer prophylaxis in rats. J Physiol Pharmacol 2001; 52: 407-421.
41. West SD, Helmer KS, Chang LK, Cui Y, Greeley GH, Mercer DW. Cholecystokinin secretagogue-induced gastroprotection: role of nitric oxide and blood flow. Am J Physiol Gastrointest Liver Physiol 2003; 284: G399-G410.
42. Allen A, Flemstrom G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev 1993; 73: 823-857.
43. Greant P, Delvaux G, Willems G. Influence of stress on epithelial cell proliferation in the gut mucosa of rats. Digestion 1988; 40: 212-218.
44. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-3577.
45. Konturek SJ, Brzozowski T, Dembinski A, Warzecha Z, Konturek PK, Yanaihara N. Interaction of growth hormonereleasing factor and somatostatin on ulcer healing and mucosal growth in rats: role of gastrin and epidermal growth factor. Digestion 1988; 41: 121-128.
46. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H. Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 1988; 94: 1300-1307.
47. Beckert S, Class N, Farrahi F, Coerper S. Growth hormone enhances gastric ulcer healing in rats. Med Sci Monit 2004; 10: BR255-BR258.
48. Sibilia V, Pagani F, Rindi G, et al. Central ghrelin gastroprotection involves nitric oxide/prostaglandin crosstalk. Br J Pharmacol 2008; 154: 688-697.
49. Lacy ER. Epithelial restitution in the gastrointestinal tract. J Clin Gastroenterol 1988; 10 (Suppl. 1): S72-S77.
50. Ahluwalia A, Li A, Cheng G, Deng X, Tarnawski AS. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis. J Physiol Pharmacol 2009; 60: 29-34.
51. Dinarello CA. A clinical perspective of IL-1b as the gatekeeper of inflammation. Eur J Immunol 2011; 41: 1203-1217.
52. Dinarello CA. Proinflammatory cytokines. Chest 2000; 118: 503-508.
53. Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsisinduced acute lung injury and mortality in rats. Am J Respir Crit Care Med 2007; 176: 805-813.
54. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
55. Tumer C, Bilgin HM, Obay BD, Diken H, Tasdemir E, Sermet A. Effect of ghrelin administration on phagocytic activity in acute cold-restraint stress exposed rats. Regul Pept 2007; 138: 113-117.
56. Ercan S, Basaranlar G, Gungor NE, et al. Ghrelin inhibits sodium metabisulfite induced oxidative stress and apoptosis in rat gastric mucosa. Food Chem Toxicol 2013; 56: 154-161.
57. Liu ZB, Fei SJ, Zhu SP, et al. Protection of ghrelin postconditioning on hypoxia/reoxygenation in gastric epithelial cells. World J Gastroenterol 2012; 18: 5377-5388.
58. Rodriguez A, Gomez-Ambrosi J, Catalan V, et al. The ghrelin O-acyltransferase-ghrelin system reduces TNF-a-induced apoptosis and autophagy in human visceral adipocytes. Diabetologia 2012; 55: 3038-3050.
59. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAIDinduced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000; 119: 706-714.
60. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013; 41: 693-705.
61. Caso JR, Leza JC, Menchen L. The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models. Curr Mol Med 2008; 8: 299-312.
62. Brzozowski T, Konturek PC, Konturek SJ, et al. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusioninduced gastric lesions. Eur J Pharmacol 1999; 385: 47-61.
63. Perini RF, Ma L, Wallace JL. Mucosal repair and COX-2 inhibition. Curr Pharm Des 2003; 9: 2207-2211.
64. He MR, Lin JQ, Song YG. Selective COX-2 inhibitor delays experimental gastric ulcer healing by stimulating gastric acid secretion in rats. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1015-1017.